← Back to news

Markets

Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire

Y

Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake

Y

Analysts reboot Micron Technology stock price target ahead of earnings

Y

Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches

Y

Citi Rates Protagonist Therapeutics (PTGX) as Buy Protagonists Drugs Opportunity

Y

Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects

Y

Wolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform’ Rating

Y

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

Y

Why We Handled Royal Caribbean Stock Differently

Y

S&P 500, Nasdaq Fall as Wall Street Ends Sideways Week of Trading with Israel-Iran in Focus

Y

Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects

Y

Acadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top Talent

Y

Here’s What You Need to Know About Jamf Holding (JAMF) Before Investing

Y

B.Riley Maintained a Buy Rating on Onto Innovation (ONTO), Keeps the PT

Y

SPHQ Adds $3.7B in Assets as Investors Seek Quality

Y

Here’s Why Globant S.A. (GLOB) Has Trembled More Than 55% This Year

Y

Braze Inc (BRZE) Has Trembled 37% During the Year, Here’s What You Need to Know Before Investing

Y

Workiva Inc. (WK) Appoints Astha Malik to Its Board of Directors

Y

Craig-Hallum Maintained a Buy Rating on Ambarella (AMBA), Keeps the PT

Y

Analyst Confidence Grows as Semtech (SMTC) Expands IoT Footprint

Y

Morgan Stanley Maintained a Buy Rating on Wix.com (WIX), Kept the PT Unchanged

Y

Here’s Why Morgan Stanley Downgraded BILL Holdings (BILL)

Y

Citi Increases PT on Oracle (ORCL), Keeps Neutral

Y

BofA Raises PT on Adobe (ADBE) Stock, Maintains Buy

Y

Wells Fargo Raises PT on Microsoft (MSFT), Keeps Overweight

Y

Needham Reiterated a Buy Rating on Zeta Global (ZETA), Kept the PT Unchanged

Y

JPMorgan Lowers PT for Occidental Petroleum (OXY), Keeps Neutral Rating

Y

Jefferies Lifts EOG Resources (EOG) Price Target, Keeps Buy Rating

Y

UBS Sticks With Buy Rating on Kinder Morgan (KMI)

Y

Stifel Cuts Schlumberger (SLB) Price Target, Keeps Buy Rating

Y

Vanguard Dividing Fund Lineups Between Two Teams

Y

Why GXO Stock Is Soaring Today

Y

Why Couchbase Stock Is Skyrocketing Today

Y

Fed governor breaks ranks with Powell, signals rate cuts could begin next month

Y

This Nuclear Energy Stock Just Got a Big Government Boost. Should You Buy It Here?

Y

Dollar and Gold Retreat on Reduced Middle East Tensions

Y

Why Shares of Kroger Are Surging Today

Y

Nvidia Might Be Getting Into the Humanoid Robot Game. Should You Buy NVDA Stock Here?

Y

Treasury Yields Fall in Fed Week Amid Geopolitical Tension

Y

Oil hedging volumes hit new records as US producers rush to lock in soaring prices

Y

Disney Just Struck a Deal with Amazon. Should You Buy DIS Stock Here?

Y

Crude Prices Slip as US Holds Back from Iran Attack

Y

Bank of Mexico seen cutting key rate by 50 basis points next week

Y

Citi Lowers ConocoPhillips (COP) Price Target, Keeps Buy Rating

Y

Wells Fargo Raises PT for Williams Companies (WMB), Keeps Overweight Rating

Y

Everyone Thinks the S&P 500 Is Too Expensive. Maybe It’s Too Cheap.

Y

Nat-Gas Prices Fall on Forecasts for Cooler US Temps

Y

2 Reasons to Sell Tesla Stock in June 2025

Y

Can I use a personal loan for anything? 6 expenses that are restricted.

Y

Darden Restaurants Sales Up as Promotions Stay Popular With Value-Oriented Consumer

Y